157 related articles for article (PubMed ID: 31752131)
1. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131
[TBL] [Abstract][Full Text] [Related]
2. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827
[TBL] [Abstract][Full Text] [Related]
4. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296
[TBL] [Abstract][Full Text] [Related]
5. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.
Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711
[TBL] [Abstract][Full Text] [Related]
6. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of the chemokine CXCL17 in colon cancer cells.
Ohlsson L; Hammarström ML; Lindmark G; Hammarström S; Sitohy B
Br J Cancer; 2016 Mar; 114(6):697-703. PubMed ID: 26889977
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of
Ismail HTH; AbdelMageed M; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562947
[TBL] [Abstract][Full Text] [Related]
9. Expression and effect of CXCL14 in colorectal carcinoma.
Lin K; Zou R; Lin F; Zheng S; Shen X; Xue X
Mol Med Rep; 2014 Sep; 10(3):1561-8. PubMed ID: 24938992
[TBL] [Abstract][Full Text] [Related]
10. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR.
Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
[TBL] [Abstract][Full Text] [Related]
12. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.
Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F
Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503
[TBL] [Abstract][Full Text] [Related]
14. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
[TBL] [Abstract][Full Text] [Related]
15. LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients.
Eltorky H; AbdelMageed M; Ismail H; Zahran F; Guirgis A; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Front Oncol; 2024; 14():1393075. PubMed ID: 38715790
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation.
Matsumura S; Demaria S
Radiat Res; 2010 Apr; 173(4):418-25. PubMed ID: 20334513
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
[TBL] [Abstract][Full Text] [Related]
18. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
19. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
20. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]